Atazanavir Sulfate

硫酸阿扎那韦

Report date: 2022/08/19 16:45:44
NME

Base Information

Drug NameAtazanavir Sulfate
Drug Alias Name硫酸他扎那韦Atazor阿扎那韦硫酸盐Atazanavirum阿扎那韦 +[11] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionHuman immunodeficiency virus type 1 protease inhibitors
TargetsHuman immunodeficiency virus type 1 protease
Therapy Area/IndicationsDiabetes Mellitus, Type 1Acquired Immunodeficiency SyndromeHIV Infections +[4] 
Global Approved IndicationsHIV Infections
Approved Indications in ChinaHIV Infections
Original Approved Country/TerritoryUnited States
Original Approved Date2003/06/20
Country/TerritoryBelgiumCanadaPanama +[38] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBristol-Myers Squibb (China) Investment Co LtdUniversity Of LiverpoolBristol-Myers Squibb Pharma Eeig +[4] 
Inactive CompaniesBristol Myers Squibb SrlcompanyThe Brigham and Women's HospitalNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsAcquired Immunodeficiency SyndromeHIV InfectionsTuberculosis
Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeJ05AE08
Related LinksWikipediaDrugBankKEGG